Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial
Christof Scheid*, Pieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Igor Wolfgang Blau, Edo Vellenga, Katja Weisel, Michael Pfreundschuh, Kon-Siong Jie, Kai Neben, Helgi van de Velde, Ulrich Duehrsen, M Ron Schaafsma, Walter Lindemann, Marie José Kersten, Norma PeterMathias Hänel, Sandra Croockewit, Hans Martin, Shulamiet Wittebol, Gerard Mj Bos, Marinus van Marwijk-Kooy, Pierre Wijermans, Hartmut Goldschmidt, Henk M Lokhorst
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial'. Together they form a unique fingerprint.